Exposure–Response Analyses of Anaplastic Lymphoma Kinase Inhibitors Crizotinib and Alectinib in Non‐Small Cell Lung Cancer Patients
2018 ◽
Vol 33
(4)
◽
pp. 549-550
2019 ◽
Vol 11
(4)
◽
pp. 1397-1409
◽
2012 ◽
2013 ◽
Vol 14
(5)
◽
pp. 597-608
◽
2018 ◽
Vol 13
(10)
◽
pp. S582
◽